Keeping it real with this midweek set of low-float/micro-cap plays, all with their own catalysts and risk profiles to dig into. None of this is financial advice, make sure you run your own full research before stepping into any positions here.
The standouts this round are Tenon Medical sitting around $10.4 with recent reverse split momentum, BioVie holding steady near $1.55 off strong Phase 2 data, and KIDZ AI hovering at $5.15 with narrowing net losses and an upcoming AI revenue tailwind rolling out Q4 2026. All of these names carry serious volatility, thin liquidity, and the usual micro-cap risk factors—no one should skip proper risk management here.
Which of these do you think has the most room to run this week?
